Pilot Study of MPDL3280A Plus Stereotactic Ablative Radiotherapy (SAR) in Stage IV Non-small Cell Lung Cancer
Phase of Trial: Phase I
Latest Information Update: 17 Feb 2017
At a glance
- Drugs Atezolizumab (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 14 Feb 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Dec 2017.
- 30 Aug 2016 Status changed from not yet recruiting to recruiting.